First, our study demonstrated that NOS2/NO expression at the mRNA (Figure 1A), protein (Figure 1B), and plasma levels (Figure 1C) was significantly higher in patients with colorectal cancer than in controls (p < 0.0001). Here, NOS2 is linked to colorectal cancer.